Biogen (BIIB) Got Lower Credit Suisse Rating And $385.0 Target; Alliant Energy Has 1.18 Sentiment

Alliant Energy Corporation operates as a utility holding firm that provides regulated electricity and natural gas services to residential, commercial, industrial, and wholesale clients in the Midwest region of the United States. The company has market cap of $9.32 billion. It operates through three divisions: Electric, Gas, and Other. It has a 21.63 P/E ratio. The company, through its subsidiary, Interstate Power and Light Company , primarily generates and distributes electricity, and distributes and transports natural gas to retail clients in Iowa; sells electricity to wholesale clients in Minnesota, Illinois, and Iowa; and generates and distributes steam in Cedar Rapids, Iowa.

Among 32 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 23 have Buy rating, 0 Sell and 9 Hold. Therefore 72% are positive. Biogen Idec Inc. has $450 highest and $268 lowest target. $364.87’s average target is -0.83% below currents $367.91 stock price. Biogen Idec Inc. had 107 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, November 8 by Mizuho. The firm has “Neutral” rating by Robert W. Baird given on Monday, July 27. Cantor Fitzgerald maintained the shares of BIIB in report on Thursday, January 25 with “Hold” rating. The firm has “Outperform” rating given on Friday, December 4 by Wells Fargo. BMO Capital Markets maintained Biogen Inc. (NASDAQ:BIIB) rating on Thursday, June 1. BMO Capital Markets has “Hold” rating and $31800 target. On Wednesday, July 26 the stock rating was maintained by BMO Capital Markets with “Market Perform”. Robert W. Baird maintained the shares of BIIB in report on Thursday, January 25 with “Hold” rating. The firm earned “Buy” rating on Thursday, January 25 by BMO Capital Markets. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Hold” rating by Jefferies on Wednesday, August 30. Piper Jaffray upgraded the shares of BIIB in report on Monday, November 7 to “Overweight” rating.

Symons Capital Management Inc holds 5.04% of its portfolio in Alliant Energy Corporation for 479,692 shares. Crow Point Partners Llc owns 588,000 shares or 3.93% of their US portfolio. Moreover, United Fire Group Inc has 3.42% invested in the company for 244,400 shares. The Virginia-based Godsey & Gibb Associates has invested 2.32% in the stock. Duff & Phelps Investment Management Co, a Illinois-based fund reported 3.37 million shares.

Since January 1, 0001, it had 0 insider purchases, and 1 sale for $85,665 activity.

The stock decreased 0.22% or $0.09 during the last trading session, reaching $40.3. About 1.48M shares traded. Alliant Energy Corporation (LNT) has risen 11.22% since January 27, 2017 and is uptrending. It has underperformed by 5.48% the S&P500.

Analysts await Alliant Energy Corporation (NYSE:LNT) to report earnings on February, 22. They expect $0.39 earnings per share, up 39.29% or $0.11 from last year’s $0.28 per share. LNT’s profit will be $90.17 million for 25.83 P/E if the $0.39 EPS becomes a reality. After $0.75 actual earnings per share reported by Alliant Energy Corporation for the previous quarter, Wall Street now forecasts -48.00% negative EPS growth.

Biogen Inc., a biopharmaceutical company, discovers, develops, makes, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company has market cap of $77.81 billion. The firm offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis ; FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It has a 30.86 P/E ratio. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies.

Since January 9, 2018, it had 0 buys, and 1 sale for $1.92 million activity. Shares for $1.92 million were sold by PANGIA ROBERT W.